| RS2543732310 |
BBS2
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 2, Bardet-Biedl syndrome 2 |
| RS2543732389 |
TSC2
|
Health Risk |
Likely pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2543732694 |
CDH3
|
Health Risk |
Pathogenic |
— |
| RS2543733239 |
BBS2
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2543733261 |
BBS2
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2543733379 |
BBS2
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 2, Bardet-Biedl syndrome 2 |
| RS2543733512 |
PRPF8
|
Health Risk |
Pathogenic |
— |
| RS2543733652 |
BBS2
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 2, Bardet-Biedl syndrome 2 |
| RS2543733653 |
PRPF8
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 13, Retinitis pigmentosa 13 |
| RS2543733677 |
BBS2
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2543734023 |
PRPF8
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder, Retinitis pigmentosa 13 |
| RS2543734076 |
PRPF8
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2543735986 |
CDH3
|
Health Risk |
Pathogenic |
— |
| RS2543737772 |
TCAP
|
Health Risk |
Pathogenic |
Primary familial hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy 25 |
| RS2543737997 |
TCAP
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 25, Primary familial hypertrophic cardiomyopathy |
| RS2543739837 |
TCAP
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy 25, Hypertrophic cardiomyopathy 25 |
| RS2543740092 |
TCAP
|
Health Risk |
Likely pathogenic |
— |
| RS2543741194 |
BBS2
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 2, Bardet-Biedl syndrome 2 |
| RS2543741333 |
BBS2
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 2, Bardet-Biedl syndrome 2 |
| RS2543741373 |
BBS2
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 2, Bardet-Biedl syndrome 2 |
| RS2543741648 |
BBS2
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2543741926 |
BBS2
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 2, Bardet-Biedl syndrome 2 |
| RS2543742094 |
BBS2
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 2, Bardet-Biedl syndrome |
| RS2543747294 |
SPG7
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 7, Hereditary spastic paraplegia 7 |
| RS2543747439 |
ADAMTS18
|
Health Risk |
Pathogenic |
— |
| RS2543751507 |
CORO1A
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency due to CORO1A deficiency, Severe combined immunodeficiency due to CORO1A deficiency |
| RS2543751607 |
WRAP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Dyskeratosis congenita, autosomal recessive 3 |
| RS2543751945 |
CORO1A
|
Health Risk |
Likely pathogenic |
Sinoatrial node disorder, Sinoatrial node disorder |
| RS2543754551 |
SPG7
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 7, Hereditary spastic paraplegia 7 |
| RS2543755742 |
BBS2
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2543755846 |
CORO1A
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency due to CORO1A deficiency, Severe combined immunodeficiency due to CORO1A deficiency |
| RS2543756421 |
ADAMTS18
|
Health Risk |
Pathogenic |
— |
| RS2543756633 |
CORO1A
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency due to CORO1A deficiency, Severe combined immunodeficiency due to CORO1A deficiency |
| RS2543759733 |
PGAP3
|
Health Risk |
Likely pathogenic |
Hyperphosphatasia with intellectual disability syndrome 4, Hyperphosphatasia with intellectual disability syndrome 4 |
| RS2543762704 |
KIAA0586
|
Health Risk |
Likely pathogenic |
Joubert syndrome 23, Short-rib thoracic dysplasia 14 with polydactyly |
| RS2543763064 |
PGAP3
|
Health Risk |
Pathogenic |
— |
| RS2543764233 |
TSC2
|
Health Risk |
Likely pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2543764309 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis syndrome |
| RS2543765063 |
PRPF8
|
Health Risk |
Likely pathogenic |
— |
| RS2543765087 |
SPG7
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 7, Hereditary spastic paraplegia 7 |
| RS2543765843 |
SPG7
|
Health Risk |
Likely pathogenic |
— |
| RS2543765925 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Lymphangiomyomatosis |
| RS2543766832 |
SPG7
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 7, Hereditary spastic paraplegia 7 |
| RS2543767299 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2543769726 |
ACSF3
|
Health Risk |
Likely pathogenic |
Combined malonic and methylmalonic acidemia, Combined malonic and methylmalonic acidemia |
| RS2543770057 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2543770114 |
ACSF3
|
Health Risk |
Likely pathogenic |
Combined malonic and methylmalonic acidemia, Combined malonic and methylmalonic acidemia |
| RS2543770251 |
ACSF3
|
Health Risk |
Likely pathogenic |
Combined malonic and methylmalonic acidemia, Combined malonic and methylmalonic acidemia |
| RS2543770258 |
PRPF8
|
Health Risk |
Pathogenic |
— |
| RS2543770296 |
ACSF3
|
Health Risk |
Likely pathogenic |
Combined malonic and methylmalonic acidemia, Combined malonic and methylmalonic acidemia |
| RS2543770313 |
ACSF3
|
Health Risk |
Likely pathogenic |
Combined malonic and methylmalonic acidemia, Combined malonic and methylmalonic acidemia |
| RS2543770473 |
ZEB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Posterior polymorphous corneal dystrophy 3, Posterior polymorphous corneal dystrophy 3 |
| RS2543773918 |
PRPF8
|
Health Risk |
Pathogenic |
— |
| RS2543786983 |
CNOT1
|
Health Risk |
Likely pathogenic |
— |
| RS2543788281 |
RPGRIP1L
|
Health Risk |
Likely pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2543791313 |
CNTNAP1
|
Health Risk |
Pathogenic |
— |
| RS2543791417 |
RPGRIP1L
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS2543791714 |
RPGRIP1L
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2543793851 |
CNTNAP1
|
Health Risk |
Likely pathogenic |
Neuropathy, congenital hypomyelinating |
| RS2543797507 |
CNTNAP1
|
Health Risk |
Likely pathogenic |
— |
| RS2543803110 |
STUB1
|
Health Risk |
Pathogenic |
Autosomal recessive spinocerebellar ataxia 16, Autosomal recessive spinocerebellar ataxia 16 |
| RS2543803363 |
STUB1
|
Health Risk |
Likely pathogenic |
Autosomal recessive spinocerebellar ataxia 16, Autosomal recessive spinocerebellar ataxia 16 |
| RS2543805016 |
STUB1
|
Health Risk |
Pathogenic |
— |
| RS2543806145 |
CNTNAP1
|
Health Risk |
Pathogenic |
— |
| RS2543806196 |
CNTNAP1
|
Health Risk |
Likely pathogenic |
Neuropathy, congenital hypomyelinating |
| RS2543809993 |
PGAP3
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2543810686 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2543814073 |
CDH1
|
Health Risk |
Likely pathogenic |
— |
| RS2543814135 |
CDH1
|
Health Risk |
Pathogenic |
Hereditary diffuse gastric adenocarcinoma, Hereditary diffuse gastric adenocarcinoma |
| RS2543814251 |
CDH1
|
Health Risk |
Pathogenic |
Hereditary diffuse gastric adenocarcinoma, Hereditary diffuse gastric adenocarcinoma |
| RS2543814268 |
CDH1
|
Health Risk |
Pathogenic |
Hereditary diffuse gastric adenocarcinoma, Hereditary diffuse gastric adenocarcinoma |
| RS2543814287 |
CDH1
|
Health Risk |
Pathogenic |
Hereditary diffuse gastric adenocarcinoma, Hereditary diffuse gastric adenocarcinoma |
| RS2543816508 |
CDH1
|
Health Risk |
Pathogenic |
Hereditary diffuse gastric adenocarcinoma, Hereditary diffuse gastric adenocarcinoma |
| RS2543816586 |
CDH1
|
Health Risk |
Pathogenic |
Hereditary diffuse gastric adenocarcinoma, Hereditary diffuse gastric adenocarcinoma |
| RS2543816722 |
CDH1
|
Health Risk |
Pathogenic |
Hereditary diffuse gastric adenocarcinoma, Hereditary diffuse gastric adenocarcinoma |
| RS2543816786 |
CDH1
|
Health Risk |
Pathogenic |
Hereditary diffuse gastric adenocarcinoma, Carcinoma of parotid gland |
| RS2543817051 |
CDH1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2543817109 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis syndrome |
| RS2543817133 |
CDH1
|
Health Risk |
Pathogenic |
Hereditary diffuse gastric adenocarcinoma, Hereditary diffuse gastric adenocarcinoma |
| RS2543817154 |
CDH1
|
Health Risk |
Pathogenic |
Hereditary diffuse gastric adenocarcinoma, Hereditary diffuse gastric adenocarcinoma |
| RS2543817165 |
CDH1
|
Health Risk |
Likely pathogenic |
Hereditary diffuse gastric adenocarcinoma, Hereditary diffuse gastric adenocarcinoma |
| RS2543817181 |
CDH1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2543817212 |
CDH1
|
Health Risk |
Pathogenic |
Hereditary diffuse gastric adenocarcinoma, Familial cancer of breast |
| RS2543817254 |
CDH1
|
Health Risk |
Likely pathogenic |
Hereditary diffuse gastric adenocarcinoma, Hereditary diffuse gastric adenocarcinoma |
| RS2543817586 |
EZH1
|
Health Risk |
Likely pathogenic |
EZH1-neurodevelopmental syndrome, EZH1-neurodevelopmental syndrome |
| RS2543818721 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2543818907 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2543820049 |
RPGRIP1L
|
Health Risk |
Likely pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2543825639 |
SPG7
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 7, Hereditary spastic paraplegia 7 |
| RS2543828455 |
TSC2
|
Health Risk |
Likely pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2543829026 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS2543831672 |
SETD1A
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with speech impairment and dysmorphic facies, Neurodevelopmental disorder with speech impairment and dysmorphic facies |
| RS2543833500 |
SETD1A
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with speech impairment and dysmorphic facies, Neurodevelopmental disorder with speech impairment and dysmorphic facies |
| RS2543833528 |
SETD1A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2543833716 |
SETD1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2543841231 |
SPOP
|
Health Risk |
Likely pathogenic |
Nabais Sa-de Vries syndrome, Nabais Sa-de Vries syndrome |
| RS2543841848 |
SETD1A
|
Health Risk |
Likely pathogenic |
— |
| RS2543843968 |
EZH1
|
Health Risk |
Likely pathogenic |
EZH1-neurodevelopmental syndrome, EZH1-neurodevelopmental syndrome |
| RS2543847896 |
SETD1A
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with speech impairment and dysmorphic facies, Neurodevelopmental disorder with speech impairment and dysmorphic facies |
| RS2543849852 |
SPG7
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 7, Hereditary spastic paraplegia 7 |